Production of polyhydroxyalkanoates from polyols
OwnerFrank A. Skraly, Martha Shollinventors
Life of this patent
Estimating the term…
Loading patent…
OwnerFrank A. Skraly, Martha Shollinventors
Estimating the term…
Recombinant processes are provided whereby additional genes are introduced into E. coli which have been genetically engineered to produce PHA so that the improved strains produce PHA homopolymers and copolymers directly from diols. In preferred embodiments, PHAs containing 4-hydroxybutyrate monomers are produced directly from 1,4-butanediol; PHAs containing 5-hydroxyvalerate are produced from 1,5-pentanediol; PHAs containing 6-hydroxyhexanoate (6HH) are produced from 1,6-hexanediol; PHAs containing 3-hydroxypropionate are produced from 1,3-propanediol; PHAs containing 2-hydroxypropionate (lactate) are produced from 1,2-propanediol (propylene glycol); PHAs containing 2-hydroxyethanoate (glycolate) are produced from 1,2-ethanediol (ethylene glycol). Genes encoding these same enzyme activities can be introduced or their expression amplified in wild type PHA producers to improve the production of PHA homopolymers and copolymers directly from diol and other alcohol feedstocks. The PHA polymers are readily recovered and industrially useful as polymers or as starting materials for a range of chemical intermediates.
A method for producing polyhydroxyalkanoates comprising
A system for making polyhydroxyalkanoates comprising an organism genetically engineered to express enzymes selected from the group consisting of a diol oxidoreductase, aldehyde dehydrogenase, acyl-CoA transferase, acyl-CoA synthetase, β-ketothiolase, acetoacetyl-CoA reductase, and PHA synthase,
A composition comprising a polyhydroxyalkanoate copolymer which includes
The composition of example 11 where the comonomer is 3-hydroxybutyrate.
The composition of example 11 where the comonomer is 4-hydroxybutyrate.
The composition of example 11 where the comonomer is 3-hydroxypropionate.
The composition of example 11 where the comonomer is 2-hydroxybutyrate.
The composition of example 11 where the comonomer is 4-hydroxyvalerate.
The composition of example 11 where the comonomer is 5-hydroxyvalerate.
The composition of example 11 where the comonomer is 6-hydroxyhexanoate.
The composition of example 11 where the comonomer is 3-hydroxyhexanoate.
A method for improving a biological system for making polyhydroxyalkanoates with an organism genetically engineered to express enzymes selected from the group consisting of a diol oxidoreductase, aldehyde dehydrogenase, acyl-CoA transferase, acyl-CoA synthetase, β-ketothiolase, acetoacetyl-CoA reductase, and PHA synthase, wherein the organism can convert diols into hydroxyalkanoate monomers which are polymerized to form polyhydroxyalkanoates, the method comprising selecting for mutants with increased enzyme activities by
A DNA fragment encoding a diol oxidoreductase and an aldehyde dehydrogenase, wherein the expressed enzymes can produce hydroxyalkanoate monomer selected from the group consisting of 3-hydroxybutyrate, 4-hydroxybutyrate, 3-hydroxypropionate, 2-hydroxybutyrate, 4-hydroxyvalerate, 5-hydroxyvalerate, 6-hydroxyhexanoate, 3-hydroxyhexanoate, 2-hydroxypropionate, and 2-hydroxyethanoate from diol.
Dependencies are inferred from the claim text.